SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹29 Cr | ₹25 Cr | ₹19 Cr | ₹31 Cr | ₹32 Cr |
What is the latest Total Non-Current Liabilities ratio of SUPRIYA LIFESCIENCE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹29 Cr |
Mar2023 | ₹25 Cr |
Mar2022 | ₹19 Cr |
Mar2021 | ₹31 Cr |
Mar2020 | ₹32 Cr |
How is Total Non-Current Liabilities of SUPRIYA LIFESCIENCE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹29 Cr | 15.72 | |
Mar2023 | ₹25 Cr | 29.23 | |
Mar2022 | ₹19 Cr | -37.22 | |
Mar2021 | ₹31 Cr | -3.10 | |
Mar2020 | ₹32 Cr | - |
Compare Total Non-Current Liabilities of peers of SUPRIYA LIFESCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUPRIYA LIFESCIENCE | ₹5,416.4 Cr | -0.9% | -7.9% | 70.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,686.0 Cr | 0.8% | -1.3% | 10.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,075.0 Cr | 1.5% | 2.3% | 47.2% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 0.9% | -3.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,971.0 Cr | -0.1% | 7.2% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,121.0 Cr | -2.7% | -0.3% | 9.9% | Stock Analytics |
SUPRIYA LIFESCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUPRIYA LIFESCIENCE | -0.9% |
-7.9% |
70.8% |
SENSEX | 0.1% |
1.2% |
6% |
You may also like the below Video Courses